Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Nov 13, 4:10 PMEnveric reported a third-quarter net loss of $2.5 million, or $0.57 per share, and $5.6 million in cash while advancing EB-003 toward a planned IND filing.
Index
-
Market Cap
6.78M
Enterprise Value
1.17M
Income
-11.25M
Sales
0.00M
Book/sh
1.28
Cash/sh
1.25
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6
IPO
Aug 22, 1995
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
1.18
P/C
1.21
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
9.70
Current Ratio
9.70
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-6.22
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
75.07% 67.96%
Sales past 3/5Y
- -
EPS Y/Y TTM
87.05%
Sales Y/Y TTM
-
EPS Q/Q
94.74%
Sales Q/Q
-
Insider Own
1.64%
Insider Trans
0.00%
Inst Own
15.78%
Inst Trans
9.41%
ROA
-175.24%
ROE
-204.82%
ROIC
-164.21%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
4.23%
SMA50
3.25%
SMA200
-20.01%
Trades
Shs Outstand
4.48M
Shs Float
4.40M
52W High
13.25 -88.57%
52W Low
1.17 29.48%
Volatility
6.53% 7.23%
ATR (14)
0.10
RSI (14)
56.02
Beta
1.19
Rel Volume
0.00
Avg Volume
71.48K
Volume
0
Perf Week
6.39%
Perf Month
8.99%
Perf Quarter
2.36%
Perf Half Y
-32.67%
Perf YTD
-58.26%
Perf Year
-72.25%
Perf 3Y
-99.45%
Perf 5Y
-99.99%
Perf 10Y
-100.00%
Prev Close
1.51
Price
1.51
Change %
0.00%
Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
CEO & DirectorDr. Joseph Edward Tucker Ph.D.
Chief Financial OfficerMr. Kevin M. Coveney CPA
Chief Innovation OfficerDr. Peter J. Facchini Ph.D.